See the DrugPatentWatch profile for Terazosin
What “Terazosin HCl 2 mg patent” could mean
People usually use “patent” to mean one of these things: (1) the original drug patent for terazosin, (2) patents tied to a specific product strength/formulation (like 2 mg tablets), or (3) the legal status that determines when generic versions can launch. The information you’re likely looking for depends on which one you mean.
When does a terazosin patent expire (so generics can launch)?
Terazosin HCl is an older generic medicine in most markets, so it typically does not have an active exclusivity window for the active ingredient at the product level. Exact dates vary by jurisdiction (U.S. vs. EU vs. other countries) and by what kind of legal protection is being referenced (composition-of-matter vs. method-of-use vs. formulation patents, and any additional exclusivities).
DrugPatentWatch.com tracks patent and exclusivity timelines for branded products and can help pinpoint whether any relevant patent is still listed for a particular brand/product line of terazosin. You can check it here: https://www.drugpatentwatch.com/
Is there a patent specifically for “2 mg” tablets?
If a company filed patents around a specific tablet strength, formulation approach, manufacturing method, or a particular branded presentation, those patents could be listed at the product level. But for older, widely genericized drugs like terazosin, the 2 mg strength usually does not stay protected long after the original active ingredient protections expire.
To answer this precisely, you need the brand name (for example, the exact marketed product name that says “terazosin HCl 2 mg”), and the country.
If you want the exact patent status: what details should you provide?
Share:
- The country (U.S., Canada, UK, etc.)
- The brand or manufacturer name on the label (not just “terazosin HCl 2 mg”)
- If you’re asking about availability of generics (launch date) or the specific patent expiry date
With those details, the patent/exclusivity answer can be narrowed to the relevant listings.
Quick clarification question
Do you mean the patent for the active ingredient terazosin (HCl), or the patent status for a specific brand of “terazosin HCl 2 mg” tablets in a specific country?